Bios Partners is a private equity firm specializing in investments within the biopharmaceutical sector, focusing on novel therapies for orphan pulmonary and fibrosis indications. The company supports clinical-stage developments, leveraging its expertise to advance medical treatments with limited existing options.
Recent Transactions involving Bios Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Aileron Therapeutics Announces Acquisition of Lung Therapeutics |
Lung Therapeutics |
Aileron Therapeutics |
Bios PartnersNantahala Capital |
Biopharmaceuticals |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →